Basket cover image
15 handpicked stocks

Bio-Hacking Portfolio

Discover companies at the cutting edge of human optimization, where biology meets technology. These carefully selected stocks represent innovators developing data-driven solutions for personalized health, enhanced performance, and extended longevity.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 1 day ago | Published at जून 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

ZEPP

Zepp Health Corp

ZEPP

Current price

$43.33

Develops smart wearable technology, including biometric sensors and AI chips, central to the bio-hacking theme of data-driven health.

MOVE

Movano Inc

MOVE

Current price

$0.65

Its Evie Ring is a prime example of a bio-hacking device, offering detailed health and wellness metrics specifically for women.

WLDS

Wearable Devices Ltd

WLDS

Current price

$1.66

Specializes in non-invasive neural input interface technology through wristbands, representing the cutting-edge of human-computer interaction.

About This Group of Stocks

1

Our Expert Thinking

This portfolio targets the growing intersection of technology and biology. As consumers increasingly seek personalized, data-driven approaches to optimize health and performance, these companies are positioned to benefit from the shift toward proactive wellness management and human enhancement.

2

What You Need to Know

These stocks span multiple sectors including biotechnology, wearable tech, nutritional supplements, and health analytics. They represent a high-growth niche market driven by consumers willing to invest in optimization of their physical and cognitive capabilities through cutting-edge products and services.

3

Why These Stocks

Each company was selected for its innovative approach to human enhancement, from advanced wearable sensors that track biometrics to genetic-level therapeutics. With strong intellectual property and clear commercialization paths, these firms are leading pioneers in the rapidly expanding bio-hacking movement.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+184.92%

Group Performance Snapshot

184.92%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 184.92% over the next year.

14 of 15

Stocks Rated Buy by Analysts

14 of 15 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🧬

The Health Revolution You Can't Ignore

Bio-hacking is transforming from niche hobby to mainstream practice as consumers increasingly take control of their health data. These companies are leading the charge toward personalized wellness.

📊

Data-Driven Growth Potential

With AI advancements accelerating product development and expanding market reach, these companies sit at the convergence of two powerful trends: personal health optimization and big data analytics.

🔮

Early Access to the Future of Wellness

Investing in bio-hacking means positioning yourself at the forefront of human enhancement technology before it becomes commonplace. These stocks represent tomorrow's approach to health today.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Consumer Caution: Value Prevails

Consumer Caution: Value Prevails

A sharp drop in consumer sentiment, driven by persistent inflation fears, signals a potential shift in household spending. This theme focuses on companies poised to benefit as consumers prioritize essential goods and seek value.

View stocks
Refining a New Opportunity: Venezuelan Crude Returns

Refining a New Opportunity: Venezuelan Crude Returns

Following a renewed U.S. license, Chevron has resumed oil shipments from Venezuela, creating a new supply of heavy crude for the market. This development presents a potential investment opportunity in U.S. refiners and logistics firms positioned to benefit from this strategic shift.

View stocks
Consumer Strength: The Retail Rebound

Consumer Strength: The Retail Rebound

A surprising surge in U.S. retail sales, driven by strong automotive and home furnishing purchases, signals continued consumer strength despite economic headwinds. This theme focuses on retailers and manufacturers in these key discretionary sectors that are benefiting from the robust consumer demand.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.